Mizolastine

MIZOLEN 10 mg COMPRIMIDOS DE LIBERACION MODIFICADA

10 mg comprimido de liberación modificadaSpainWithdrawnAuthorised 28 Feb 1998

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

MizollenItaly · Compressa a rilascio modificato · Opella Healthcare Italy S.R.L.Same form
ZolistamItaly · Compressa a rilascio modificato · Opella Healthcare Italy S.R.L.Same form
Mizollen 10 mg, tabletten met gereguleerde afgifteNetherlands · Tablet met gereguleerde afgifte · Opella Healthcare France S.A.S.Same form

Packs

Pack	Code	Status
MIZOLEN 10 mg COMPRIMIDOS DE LIBERACION MODIFICADA, 20 comprimidos	665356

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Mizolastine

MIZOLEN 10 mg COMPRIMIDOS DE LIBERACION MODIFICADA

10 mg comprimido de liberación modificadaSpainWithdrawnAuthorised 28 Feb 1998

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
MIZOLEN 10 mg COMPRIMIDOS DE LIBERACION MODIFICADA, 20 comprimidos	665356

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Mizolastine
Strength: 10 mg
Dosage form: comprimido de liberación modificada
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 28 Feb 1998
Registration: 61658
Marketing authorisation holder: Opella Healthcare Spain S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica